Rx · PZN 19279513, 19477495
WEZENLA 45 mg solution for injection vial
German trade nameWEZENLA 45 mg Injektionslösung Durchstechflasche
Only sporadically available
1.3out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for WEZENLA 45 mg solution for injection vial.
Review purchasing termsWEZENLA 45 mg solution for injection vial contains the active ingredient Ustekinumab and comes as Solution for injection/infusion. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 1.3 out of 10. The best-available pack was only sporadically available.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 19279513 | 1.3 | 1.3 | ~ €2,351 |
| 19477495 | 0.0 | 0.0 | ~ €2,351 |
WEZENLA 45 mg solution for injection vial was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.
Request a source of supply